secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2023-04-03T23:59:59+00:00
Accession:  0001356576-23-000020
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus borrows $93M under credit line, repays $402.5M convertible notes due 2023
--------------------------------------------------------------------------------

- Borrowed $93M from UBS Bank USA on March 30, 2023 under a $150M revolving credit line.
- Used proceeds plus available cash to repay the full $402.5M principal and $1.3M interest on its 0.625% Convertible Senior Notes due April 2023.
- Credit line is secured by company accounts, securities, and investment property held at UBS.
- Following repayment, the 2023 Notes are no longer outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657623000020/0001356576-23-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657623000020/supn-20230330.htm
  HTML page:      https://secwatch.observer/filing/0001356576-23-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer